Annual Display of Biologics

Molecular evolution using the tools of phage, yeast, bacterial and other display methods have yielded a staggering array of bispecific antibodies, antibody-drug conjugates, immunotherapies and other constructs. The emergence of AI, machine learning, deep sequencing, and computational tools will be applied to improve design and efficacy of candidates. Strategies to develop synthetic libraries will be explored, along with the use of phage display to alter the functional activity of antibodies.